A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan (20 mg) and Lansoprazole (30 mg) in Healthy Subjects
Phase: PHASE1
Conditions: Healthy Participants
Sponsor: Phathom Pharmaceuticals, Inc.

Protocol Number:  VONO-103 
 
Official Title:  A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the 
Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan (20 mg) and 
Lansoprazole (30 mg) in Healthy Subjects 
 
NCT Number: NCT04729101 
 
Document Date: 15-Apr-2021